Collagen I-based scaffolds negatively impact fracture healing in a mouse-osteotomy-model although used routinely in research and clinical application.

[1]  Y. Ezura,et al.  Annexin A5 Involvement in Bone Overgrowth at the Enthesis , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Bin Huang,et al.  Positive‐Feedback Regulation of Subchondral H‐Type Vessel Formation by Chondrocyte Promotes Osteoarthritis Development in Mice , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  G. Duda,et al.  The Interaction of BMP2‐Induced Defect Healing in Rat and Fixator Stiffness Modulates Matrix Alignment and Contraction , 2018, JBMR plus.

[4]  M. Ebrahimzadeh,et al.  Current Concepts in Scaffolding for Bone Tissue Engineering. , 2018, The archives of bone and joint surgery.

[5]  Hyun-Dong Chang,et al.  Longitudinal intravital imaging of the femoral bone marrow reveals plasticity within marrow vasculature , 2017, Nature Communications.

[6]  C. Vacher,et al.  Strategies Developed to Induce, Direct, and Potentiate Bone Healing , 2017, Front. Physiol..

[7]  G. Pei,et al.  CD31hiEmcnhi Vessels Support New Trabecular Bone Formation at the Frontier Growth Area in the Bone Defect Repair Process , 2017, Scientific Reports.

[8]  Gopal Shankar Krishnakumar,et al.  Clinical application of bone morphogenetic proteins for bone healing: a systematic review , 2017, International Orthopaedics.

[9]  W. Jiskoot,et al.  Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration , 2017, Pharmaceutical Research.

[10]  Juan M. Vaquerizas,et al.  Cell-matrix signals specify bone endothelial cells during developmental osteogenesis , 2017, Nature Cell Biology.

[11]  Annemarie Lang,et al.  Osteotomy models – the current status on pain scoring and management in small rodents , 2016, Laboratory animals.

[12]  Wayne A Morrison,et al.  Three Dimensional Collagen Scaffold Promotes Intrinsic Vascularisation for Tissue Engineering Applications , 2016, PloS one.

[13]  B. Levy,et al.  Specialized pro-resolving mediators: endogenous regulators of infection and inflammation , 2015, Nature Reviews Immunology.

[14]  Elena García-Gareta,et al.  Osteoinduction of bone grafting materials for bone repair and regeneration. , 2015, Bone.

[15]  Z. Bi,et al.  Bone morphogenetic protein 2 and decorin expression in old fracture fragments and surrounding tissues. , 2015, Genetics and molecular research : GMR.

[16]  Zohaib Khurshid,et al.  Biodegradable Materials for Bone Repair and Tissue Engineering Applications , 2015, Materials.

[17]  R. Poulsom,et al.  Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response , 2015, EMBO molecular medicine.

[18]  K. Ting,et al.  Fibromodulin Enhances Angiogenesis during Cutaneous Wound Healing , 2014, Plastic and reconstructive surgery. Global open.

[19]  T. J. Weber,et al.  Impaired Osteoblast Differentiation in Annexin A2- and -A5-Deficient Cells , 2014, PloS one.

[20]  C. Tomasi,et al.  Ridge preservation with the use of deproteinized bovine bone mineral. , 2014, Clinical oral implants research.

[21]  C. Serhan.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[22]  Hamish Simpson,et al.  Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. , 2014, Injury.

[23]  R. Adams,et al.  Endothelial Notch activity promotes angiogenesis and osteogenesis in bone , 2014, Nature.

[24]  R. Adams,et al.  Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.

[25]  Thomas L. Smith,et al.  Reduction of ectopic bone growth in critically-sized rat mandible defects by delivery of rhBMP-2 from kerateine biomaterials. , 2014, Biomaterials.

[26]  H. An,et al.  Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery. , 2014, The spine journal : official journal of the North American Spine Society.

[27]  G. Prestwich,et al.  The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation. , 2013, Acta biomaterialia.

[28]  M. Boakye,et al.  Cancer after spinal fusion: the role of bone morphogenetic protein. , 2013, Neurosurgery.

[29]  J. Kanis,et al.  Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  V. Chiono,et al.  Collagen for bone tissue regeneration. , 2012, Acta biomaterialia.

[31]  Andrés J. García,et al.  Effects of protein dose and delivery system on BMP-mediated bone regeneration. , 2011, Biomaterials.

[32]  G. Duda,et al.  Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas , 2011, Immunologic research.

[33]  G. Duda,et al.  Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics. , 2011, European cells & materials.

[34]  Ralph Müller,et al.  Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  V. Sonntag,et al.  Formation of Painful Seroma and Edema After the Use of Recombinant Human Bone Morphogenetic Protein‐2 in Posterolateral Lumbar Spine Fusions , 2010, Neurosurgery.

[36]  A. Schilling,et al.  BMP‐7–induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6‐mice , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[37]  D. Lorich,et al.  Complications of Recombinant Human BMP-2 for Treating Complex Tibial Plateau Fractures: A Preliminary Report , 2009, Clinical orthopaedics and related research.

[38]  R. Iozzo,et al.  Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction* , 2008, Journal of Biological Chemistry.

[39]  T. Jämsä,et al.  Reindeer BMP extract in the healing of critical-size bone defects in the radius of the rabbit , 2006, Acta orthopaedica.

[40]  Seong-Ho Choi,et al.  Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. , 2005, Biomaterials.

[41]  F. Lecanda,et al.  Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter. , 2005, The Biochemical journal.

[42]  Enrico Tessitore,et al.  The use of local agents: bone wax, gelatin, collagen, oxidized cellulose , 2004, European Spine Journal.

[43]  U. Rinas,et al.  Optimized procedure for renaturation of recombinant human bone morphogenetic protein‐2 at high protein concentration , 2004, Biotechnology and bioengineering.

[44]  W. Friess,et al.  Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.

[45]  E. Schönherr,et al.  Differential roles for small leucine-rich proteoglycans in bone formation. , 2003, European cells & materials.

[46]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[47]  H. Seeherman,et al.  Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: A comparison of rhBMP‐2, cancellous bone graft, and absorbable collagen sponge , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[48]  H. Seeherman,et al.  The effect of recombinant human bone morphogenetic protein‐2 on femoral reconstruction with an intercalary allograft in a dog model , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[49]  H. Uludaǧ,et al.  Bone regeneration with recombinant human bone morphogenetic protein-2 (rhBMP-2) using absorbable collagen sponges (ACS): influence of processing on ACS characteristics and formulation. , 1999, Pharmaceutical development and technology.

[50]  S. Bulstra,et al.  Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect , 1999 .

[51]  William A. Pierce,et al.  Effect of Recombinant Human Bone Morphogenetic Protein‐2 on Fracture Healing in a Goat Tibial Fracture Model , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  K. Kadler,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, The Journal of cell biology.

[53]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[54]  L. Bonewald,et al.  Osteoinductive factor inhibits formation of human osteoclast-like cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Segarini,et al.  Purification and characterization of a unique osteoinductive factor from bovine bone. , 1989, The Journal of biological chemistry.

[56]  K. Black,et al.  A Comparison of hemostatic agents in microvascular surgery , 1982, Journal of microsurgery.

[57]  W. Harris,et al.  Topical hemostatic agents for bone bleeding in humans. A quantitative comparison of gelatin paste, gelatin sponge plus bovine thrombin, and microfibrillar collagen. , 1978, The Journal of bone and joint surgery. American volume.

[58]  L. Morgenstern.  Microcrystalline collagen used in experimental splenic injury. A new surface hemostatic agent. , 1974, Archives of surgery.

[59]  M. Urist,et al.  Bone Morphogenetic Protein , 1971, Journal of dental research.

[60]  R. Merritt.  Microcrystalline collagen. A new hemostatic agent. , 1970 .

[61]  G. Duda,et al.  Macrophages in bone fracture healing: Their essential role in endochondral ossification. , 2018, Bone.

[62]  Kuiliang Liu,et al.  Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin αvβ3/focal adhesion kinase pathways. , 2017, Drug discoveries & therapeutics.

[63]  R. Gruber,et al.  Alveolar bone regeneration in response to local application of calcitriol in vitamin D deficient rats. , 2015, Journal of clinical periodontology.

[64]  T. Kawamoto,et al.  Preparation of thin frozen sections from nonfixed and undecalcified hard tissues using Kawamot's film method (2012). , 2014, Methods in molecular biology.

[65]  G. Duda,et al.  Mechanical load modulates the stimulatory effect of BMP2 in a rat nonunion model. , 2013, Tissue engineering. Part A.

[66]  M. Cifuentes,et al.  Osteogenic molecules for clinical applications: improving the BMP-collagen system. , 2013, Biological research.

[67]  Le Zhang,et al.  The roles of annexins and alkaline phosphatase in mineralization process. , 2003, Acta biochimica Polonica.

[68]  D. Szukiewicz,et al.  Review Article Transforming Growth Factor Beta Family: Insight into the Role of Growth Factors in Regulation of Fracture Healing Biology and Potential Clinical Applications , 2022 .